Javascript must be enabled to continue!
Systems Biology and Synthetic Biology: A New Epoch for Toxicology Research
View through CrossRef
Systems biology and synthetic biology are emerging disciplines which are becoming increasingly utilised in several areas of bioscience. Toxicology is beginning to benefit from systems biology and we suggest in the future that is will also benefit from synthetic biology. Thus, a new era is on the horizon. This review illustrates how a suite of innovative techniques and tools can be applied to understanding complex health and toxicology issues. We review limitations confronted by the traditional computational approaches to toxicology and epidemiology research, using polycyclic aromatic hydrocarbons (PAHs) and their effects on adverse birth outcomes as an illustrative example. We introduce how systems toxicology (and their subdisciplines, genomic, proteomic, and metabolomic toxicology) will help to overcome such limitations. In particular, we discuss the advantages and disadvantages of mathematical frameworks that computationally represent biological systems. Finally, we discuss the nascent discipline of synthetic biology and highlight relevant toxicological centred applications of this technique, including improvements in personalised medicine. We conclude this review by presenting a number of opportunities and challenges that could shape the future of these rapidly evolving disciplines.
Title: Systems Biology and Synthetic Biology: A New Epoch for Toxicology Research
Description:
Systems biology and synthetic biology are emerging disciplines which are becoming increasingly utilised in several areas of bioscience.
Toxicology is beginning to benefit from systems biology and we suggest in the future that is will also benefit from synthetic biology.
Thus, a new era is on the horizon.
This review illustrates how a suite of innovative techniques and tools can be applied to understanding complex health and toxicology issues.
We review limitations confronted by the traditional computational approaches to toxicology and epidemiology research, using polycyclic aromatic hydrocarbons (PAHs) and their effects on adverse birth outcomes as an illustrative example.
We introduce how systems toxicology (and their subdisciplines, genomic, proteomic, and metabolomic toxicology) will help to overcome such limitations.
In particular, we discuss the advantages and disadvantages of mathematical frameworks that computationally represent biological systems.
Finally, we discuss the nascent discipline of synthetic biology and highlight relevant toxicological centred applications of this technique, including improvements in personalised medicine.
We conclude this review by presenting a number of opportunities and challenges that could shape the future of these rapidly evolving disciplines.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
Klasifikasi Kain Tenun Sumba menggunakan Jaringan Saraf Tiruan
Klasifikasi Kain Tenun Sumba menggunakan Jaringan Saraf Tiruan
The evaluation results with epoch 100 have quite good classification accuracy. The correct accuracy value of the classification is 60% of the test data. In other words, the results...
Outcomes of Treatment With CHOP and EPOCH in Patients With HIV Associated NHL in a Low Resource Setting
Outcomes of Treatment With CHOP and EPOCH in Patients With HIV Associated NHL in a Low Resource Setting
Abstract
Background: The optimal chemotherapy regimen for treating HIV associated NHL in low resource settings is unknown. We conducted a retrospective study to describe su...
Evaluation of Optimal Epoch Lengths for Real-Time Physical Activity Measurement for mHealth Applications: Cross-Sectional Study (Preprint)
Evaluation of Optimal Epoch Lengths for Real-Time Physical Activity Measurement for mHealth Applications: Cross-Sectional Study (Preprint)
BACKGROUND
Wearable accelerometers have become integral to mobile health (mHealth) research, particularly for delivering real-time physical activity (PA) monitori...
Identifikasi Penyakit COVID-19 dan Tuberkulosis Menggunakan Metode Convolutional Neural Network Arsitektur GoogLeNet Berdasarkan Citra Rontgen Thorax
Identifikasi Penyakit COVID-19 dan Tuberkulosis Menggunakan Metode Convolutional Neural Network Arsitektur GoogLeNet Berdasarkan Citra Rontgen Thorax
Penelitian identifikasi penyakit COVID-19 dan tuberkulosis berdasarkan rontgen thorax dengan metode convolutional neural network (CNN) arsitektur GoogLeNet telah dilakukan untuk me...
Toxicology research for precautionary decision-making and the role of Human & Experimental Toxicology
Toxicology research for precautionary decision-making and the role of Human & Experimental Toxicology
A key aim of toxicology is the prevention of adverse effects due to toxic hazards. Therefore, the dissemination of toxicology research findings must confront two important challeng...

